In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance 'tylvalosin' is replaced by the following:
Pharmacologically active substance | Marker residue | Animal species | MRL | Target tissues | Other provisions (according to Article 14(7) of Regulation (EC) No 470/2009) | Therapeutic classification
‘Tylvalosin | Tylvalosin | Porcine |
50 μg/kg
50 μg/kg
50 μg/kg
50 μg/kg
Muscle
Skin and fat
Liver
Kidney
NO ENTRY | Anti-infectious agents/Antibiotics’
Poultry | 200 μg/kg | Eggs
Sum of Tylvalosin and 3-0-acetyltylosin | Poultry |
50 μg/kg
50 μg/kg
Skin and fat
Liver